Nuclear models

por Nemirovskij, P E, Chomet, S
Publicado 1963

State of the Art in Radiolabeling of Antibodies with Common and Uncommon Radiometals for Preclinical and Clinical Immuno-PET

por Chomet, Marion, van Dongen, Guus A. M. S., Vugts, Danielle J.
Publicado 2021

The tumor targeting performance of anti-CD166 Probody drug conjugate CX-2009 and its parental derivatives as monitored by (89)Zr-immuno-PET in xenograft bearing mice

por Chomet, Marion, Schreurs, Maxime, Nguyen, Margaret, Howng, Bruce, Villanueva, Ruth, Krimm, Michael, Vasiljeva, Olga, van Dongen, Guus A.M.S, Vugts, Danielle J.
Publicado 2020

Pretargeted PET Imaging with a TCO-Conjugated Anti-CD44v6 Chimeric mAb U36 and [(89)Zr]Zr-DFO-PEG(5)-Tz

por Lumen, Dave, Vugts, Danielle, Chomet, Marion, Imlimthan, Surachet, Sarparanta, Mirkka, Vos, Ricardo, Schreurs, Maxime, Verlaan, Mariska, Lang, Pauline A., Hippeläinen, Eero, Beaino, Wissam, Windhorst, Albert D., Airaksinen, Anu J.
Publicado 2022

Performance of nanoScan PET/CT and PET/MR for quantitative imaging of (18)F and (89)Zr as compared with ex vivo biodistribution in tumor-bearing mice

por Chomet, Marion, Schreurs, Maxime, Vos, Ricardo, Verlaan, Mariska, Kooijman, Esther J., Poot, Alex J., Boellaard, Ronald, Windhorst, Albert D., van Dongen, Guus AMS, Vugts, Danielle J., Huisman, Marc C., Beaino, Wissam
Publicado 2021

Head-to-head comparison of DFO* and DFO chelators: selection of the best candidate for clinical (89)Zr-immuno-PET

por Chomet, Marion, Schreurs, Maxime, Bolijn, Maria J., Verlaan, Mariska, Beaino, Wissam, Brown, Kari, Poot, Alex J., Windhorst, Albert D., Gill, Herman, Marik, Jan, Williams, Simon, Cowell, Joseph, Gasser, Gilles, Mindt, Thomas L., van Dongen, Guus A. M. S, Vugts, Danielle J.
Publicado 2020